Summary
For Year 2026-27, Sai Life Sciences reports the following shareholding: Total Promoters at 34.61%, Mutual Fund at 27.8%, Insurance at 3.07%, Foreign Institutional Investors at 21.17%, Domestic Institutional Investors at 0.67%, and Retail at 12.68%. This breakdown provides a quick snapshot of ownership distribution for Sai Life Sciences in 2026-27.
Sai Life Sciences FAQs
As of 04-2026, the promoter shareholding in Sai Life Sciences stands at 34.61% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Sai Life Sciences is 21.17% and 0.67% respectively.
The retail shareholding of the Sai Life Sciences is 12.68%.
Changes in shareholding patterns of Sai Life Sciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Sai Life Sciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
